Mayur Parmar

ORCID: 0000-0003-4970-9857
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Alzheimer's disease research and treatments
  • Parkinson's Disease Mechanisms and Treatments
  • Nuclear Receptors and Signaling
  • Cellular transport and secretion
  • COVID-19 Clinical Research Studies
  • Nerve injury and regeneration
  • Long-Term Effects of COVID-19
  • COVID-19 Impact on Reproduction
  • Pharmacology and Obesity Treatment
  • Neuroscience and Neuropharmacology Research
  • Sirtuins and Resveratrol in Medicine
  • CRISPR and Genetic Engineering
  • RNA Interference and Gene Delivery
  • Receptor Mechanisms and Signaling
  • Trace Elements in Health
  • SARS-CoV-2 and COVID-19 Research
  • Maternal Mental Health During Pregnancy and Postpartum
  • Diabetes Treatment and Management
  • Biosimilars and Bioanalytical Methods
  • Cancer-related Molecular Pathways
  • Advanced Glycation End Products research
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Poisoning and overdose treatments
  • Peripheral Neuropathies and Disorders
  • Melanoma and MAPK Pathways

Nova Southeastern University
2020-2024

Saurashtra University
2023-2024

Barry University
2023

Richmond University Medical Center
2023

Gujarat Cancer Society
2022

Florida Gulf Coast University
2022

AdventHealth Tampa
2022

Florida College
2019

University of Florida
2017-2019

Mylan (United States)
2017

Passive immunization with anti-tau monoclonal antibodies has been shown by several laboratories to reduce age-dependent tau pathology and neurodegeneration in mutant transgenic mice. These studies have used repeated high weekly doses of various administered systemically for months reported reduced ∼40-50% brain regions. Here we show that direct intrahippocampal administration the adeno-associated virus (AAV)-vectored anti-phospho-tau antibody PHF1 P301S mice results durable expression,...

10.1523/jneurosci.2016-16.2016 article EN cc-by-nc-sa Journal of Neuroscience 2016-12-07

Ivermectin was first discovered in the 1970s by Japanese microbiologist Satoshi Omura and Irish parasitologist William C. Campbell. has become a versatile pharmaceutical over past 50 years. is derivative of avermectin originally used to treat parasitic infections. Emerging literature suggested that its role goes beyond this may help inflammatory conditions, viral infections, cancers. Ivermectin's anti-parasitic, anti-inflammatory, anti-viral, anticancer effects were explored. Its traditional...

10.7759/cureus.56025 article EN Cureus 2024-03-12

Type I Diabetes is characterized by the presence of hyperglycemia due to insulin deficiency and consequent impaired hepatic glucose metabolism. During diabetes, liver becomes most important tissue for regulation serum glucose. However, elevated causes continuous oxidative damage liver, reducing its capacity ameliorate hyperglycemia, which contributes macrovascular complications [1]. Numerous epidemiological studies have demonstrated that excess human consumption diets rich in specific...

10.2174/1567202612666150812150249 article EN Current Neurovascular Research 2015-09-08
Coming Soon ...